The biotechnology company reported ($0.16) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.24) by $0.08.
11
Dec
Leave a Reply
You must be logged in to post a comment.
The biotechnology company reported ($0.16) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.24) by $0.08.
You must be logged in to post a comment.